Multidimensional analysis of clinicopathological characteristics of false-negative clinically significant prostate cancers on multiparametric MRI of the prostate in Japanese men

被引:10
|
作者
Kido, Ayumu [1 ]
Tamada, Tsutomu [1 ]
Kanomata, Naoki [2 ]
Yamamoto, Akira [1 ]
Miyaji, Yoshiyuki [3 ]
Nagai, Atsushi [3 ]
Sone, Teruki [1 ]
机构
[1] Kawasaki Med Sch, Dept Radiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
[2] Kawasaki Med Sch, Dept Pathol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
[3] Kawasaki Med Sch, Dept Urol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan
关键词
Magnetic resonance imaging; Prostate cancer; Tumor detection; Prostate imaging and reporting data system version 2; Dynamic contrast-enhanced MR imaging; RESONANCE-IMAGING CORRELATION; RADICAL PROSTATECTOMY; VERSION; FUSION BIOPSY; IMPACT; CARCINOMA; ACCURACY; PATTERNS; OUTCOMES; TRENDS;
D O I
10.1007/s11604-018-0801-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PurposeTo clarify clinicopathological features of false-negative clinically significant prostate cancer (csPC) at multiparametric prostate MRI (mpMRI).Methods95 patients with 139 csPC undergoing 3T mpMRI before radical prostatectomy were included. Two radiologists were independently evaluated mpMR images using PI-RADS v2. Clinicopathological findings were compared between (a) detectable and undetectable lesions using overall mpMRI criteria (o-mpMRI criteria) and (b) lesions with early enhancement effect (EEE) and lesions without EEE at DCE-MRI.ResultsThe detection rate of csPS using cutoff value of category 3 or more in PI-RADS v2 for positive lesion was 72.1% (98/136 lesions). In 38 false-negative lesions with less than PI-RADS v2 category 3, the DCE-MRI detected 14 lesions. 17 undetectable lesions on o-mpMR criteria had lower PSA and D'amico risk classification, and higher tumor apparent diffusion coefficient (ADC) than those of 118 detectable lesions (p0.048). 89 lesions with EEE showed higher PSA, tumor size, prostatectomy GS grade, frequency of lesions with GS4+3 and lower tumor ADC than those in 38 lesions without EEE (p0.046).ConclusionTumor detectability of csPC with PI-RADS v2 was limited compared with o-mpMRI criteria in Japanese men. Moreover, false-negative lesions on o-mpMRI criteria were characterized as small in size, low risk and low cellularity.
引用
收藏
页码:154 / 164
页数:11
相关论文
共 50 条
  • [31] Radiologists' Contribution to Variation in Detecting Clinically Significant Prostate Cancer in Men With Prostate MRI
    Naik, Sachin
    Burk, Kristine S.
    Budiawan, Elvira
    Lacson, Ronilda
    Lee, Leslie K.
    Fennessy, Fiona M.
    Tempany, Clare
    Cole, Alexander P.
    Trinh, Quoc-Dien
    Kibel, Adam S.
    Khorasani, Ramin
    JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2022, 19 (12) : 1312 - 1321
  • [32] Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
    Mo, Li-Cai
    Zhang, Xian-Jun
    Zheng, Hai-Hong
    Huang, Xiao-peng
    Zheng, Lin
    Zhou, Zhi-Rui
    Wang, Jia-Jia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [33] A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI
    Kasivisvanathan, Veeru
    Ambrosi, Alessandro
    Giganti, Francesco
    Chau, Edwin
    Kirkham, Alex
    Punwani, Shonit
    Allen, Clare
    Emberton, Mark
    Moore, Caroline M.
    EUROPEAN UROLOGY, 2019, 75 (01) : 203 - 204
  • [34] Habitats in DCE-MRI to Predict Clinically Significant Prostate Cancers
    Parra, Nestor Andres
    Lu, Hong
    Choi, Jung
    Gage, Kenneth
    Pow-Sang, Julio
    Willies, Robert J.
    Balagurunathan, Yoganand
    TOMOGRAPHY, 2019, 5 (01) : 68 - 76
  • [35] Prediction of Clinically Significant Prostate Cancer Using Multiparametric MRI, Biparametric MRI, and Clinical Parameters
    Oberneder, Maximilian
    Henzler, Thomas
    Kriegmair, Martin
    Vag, Tibor
    Roethke, Matthias
    Siegert, Sabine
    Lang, Roland
    Lenk, Julia
    Gawlitza, Joshua
    UROLOGIA INTERNATIONALIS, 2024,
  • [36] BIPARAMETRIC MRI PERFORMANCE IS COMPARABLE TO MULTIPARAMETRIC MRI FOR THE ACCURATE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER
    Pickersgill, Nicholas A.
    Shiang, Alex L.
    Vetter, Joel M.
    Barashi, Nimrod
    Sheng, John
    Ippolito, Joseph E.
    Kim, Eric H.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E307 - E307
  • [37] Prospective Inclusion of Apparent Diffusion Coefficients in Multiparametric Prostate MRI Structured Reports: Discrimination of Clinically Insignificant and Significant Cancers
    Costa, Daniel N.
    Xi, Yin
    Aziz, Muhammad
    Passoni, Niccolo
    Shakir, Nabeel
    Goldberg, Kenneth
    Francis, Franto
    Roehrborn, Claus G.
    de Leon, Alberto Diaz
    Pedrosa, Ivan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (01) : 109 - 116
  • [38] What is the negative predictive value of multiparametric MRI in excluding clinically significant prostate cancer at biopsy? Results from 1000 multiparametric MRIs
    Stanowski, M.
    Lobo, N.
    Petrides, N.
    Morrison, I.
    Eraibey, M.
    Thomas, M.
    Kommu, S.
    Streeter, E.
    Eddy, B.
    BJU INTERNATIONAL, 2020, 125 : 107 - 108
  • [39] Multiparametric MRI Fusion-Guided Prostate Biopsy for Detection of Clinically Significant Prostate Cancer Eliminates the Systemic Prostate Biopsy
    Matulevicius, Augustinas
    Bakavicius, Arnas
    Ulys, Albertas
    Trakymas, Mantas
    Usinskiene, Jurgita
    Naruseviciute, Ieva
    Sabaliauskaite, Rasa
    Zukauskaite, Kristina
    Jarmalaite, Sonata
    Jankevicius, Feliksas
    APPLIED SCIENCES-BASEL, 2022, 12 (19):
  • [40] Comparison of Multiparametric and Fast MRI Protocols in Detecting Clinically Significant Prostate Cancer and a Detailed Cost Analysis
    Alver, Kadir Han
    Yagci, Ahmet Baki
    Utebey, Ayse Ruksan
    Sen Turk, Nilay
    Ufuk, Furkan
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2022, 56 (05) : 1437 - 1447